Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Molecule docking has been regarded as a routine tool for drug discovery, but its accuracy highly depends on the reliability of scoring functions (SFs). With the rapid development of machine learning (ML) techniques, ML‐based SFs have gradually emerged as a promising alternative for protein–ligand binding affinity prediction and virtual screening, and most of them have shown significantly better performance than a wide range of classical SFs. Emergence of more data‐hungry deep learning (DL) approaches in recent years further fascinates the exploitation of more accurate SFs. Here, we summarize the progress of traditional ML‐based SFs in the last few years and provide insights into recently developed DL‐based SFs. We believe that the continuous improvement in ML‐based SFs can surely guide the early‐stage drug design and accelerate the discovery of new drugs.
This article is categorized under:
Computer and Information Science > Chemoinformatics
This overview summarizes the progress of traditional ML‐based SFs in the last few years and provides insights into recently developed DL‐based SFs